Page last updated: 2024-10-24

carbamazepine and Scleroderma, Systemic

carbamazepine has been researched along with Scleroderma, Systemic in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campello, I1
Velilla, J1
Almárcegui, C1
Pérez López-Fraile, I1

Other Studies

1 other study available for carbamazepine and Scleroderma, Systemic

ArticleYear
[Trigeminal neuropathy in progressive systemic sclerosis. Letter].
    Revista de neurologia, 1997, Volume: 25, Issue:137

    Topics: Aged; Anticonvulsants; Brain Diseases; Carbamazepine; Female; Humans; Scleroderma, Systemic; Trigemi

1997